Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)EBIATLeasesLoans and Notes ReceivablesLong-Term Debt IssuancesNon-Current ReceivablesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetShort-Term Debt repayments
Ratios

Cosmos Health (COSM) Loans and Notes Receivables (2023 - 2025)

Cosmos Health (COSM) has disclosed Loans and Notes Receivables for 3 consecutive years, with $714935.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Loans and Notes Receivables rose 45.34% year-over-year to $714935.0, compared with a TTM value of $714935.0 through Sep 2025, up 45.34%, and an annual FY2024 reading of $614473.0, up 49.2% over the prior year.
  • Loans and Notes Receivables was $714935.0 for Q3 2025 at Cosmos Health, up from $615592.0 in the prior quarter.
  • Across five years, Loans and Notes Receivables topped out at $714935.0 in Q3 2025 and bottomed at $407318.0 in Q1 2024.
  • Average Loans and Notes Receivables over 3 years is $545127.1, with a median of $553185.0 recorded in 2024.
  • Peak annual rise in Loans and Notes Receivables hit 63.56% in 2025, while the deepest fall reached 40.32% in 2025.
  • Year by year, Loans and Notes Receivables stood at $411858.0 in 2023, then soared by 49.2% to $614473.0 in 2024, then grew by 16.35% to $714935.0 in 2025.
  • Business Quant data shows Loans and Notes Receivables for COSM at $714935.0 in Q3 2025, $615592.0 in Q2 2025, and $666225.0 in Q1 2025.